Clinical Chemistry
Specimens
2 liquid human serum samples, 2 mL.
Examinations
AFP, CA 125, CA 153, CA 199, CEA, ferritin, hCG (total, intact, beta-subunit), PSA, PSA free, PSA free/total index, TG, TG antibodies, beta-2-microglobulin, NSE, HE4.
Important Notes
2700S is a limited version of the scheme available for laboratories performing testing of 1–5 analytes. Product 2700S does not include reporting from multiple analysers or methods.
Clinical Chemistry
Specimens
2 liquid human serum samples, 2 mL.
Examinations
AFP, CA 125, CA 153, CA 199, CEA, ferritin, hCG (total, intact, beta-subunit), PSA, PSA free, PSA free/total index, TG, TG antibodies, beta-2-microglobulin, NSE, HE4.
Important Notes
2700S is a limited version of the scheme available for laboratories performing testing of 1–5 analytes. Product 2700S does not include reporting from multiple analysers or methods.
Microbiology
Specimens
2 lyophilised samples and dilutor. Brief case histories also given. Pre- and/or post-analytical cases in part of the rounds
Examinations
Culture and quantitation, pre-and/or post-analytical indicators
Important Notes
Scheme 3170 available for urine bacterial screening with automated analysers.
Microbiology
Specimens
2 lyophilised samples and dilutor. Brief case histories also given. The samples intended for susceptibility testing may include both international quality control strains and susceptible or resistant clinical strains. Pre- and/or post-analytical cases in part of the rounds
Examinations
Culture, quantitation, identification and antimicrobial susceptibility testing, pre-and/or post-analytical indicators
Important Notes
Scheme 3170 available for urine bacterial screening with automated analysers.
Clinical Chemistry
Specimens
1 lyophilized urine sample with varying concentrations, 15 mL.
Examinations
Glucose, ketone bodies, leukocytes, nitrite, pH, protein, blood (erythrocytes), relative density.
Important Notes
For clinical laboratories and POCT sites. Water for dissolution available, see scheme 3101, should be ordered separately.
Clinical Chemistry
Specimens
15 mL, water for dissolution of samples of scheme 3100 and 3102
Examinations
Water for dissolution
Important Notes
Only in connection with scheme 3100 and 3102
Clinical Chemistry
Specimens
1 lyophilized urine sample with varying concentrations, 15 mL
Examinations
Bilirubin, glucose, ketone bodies, leukocytes, nitrite, pH, protein, blood (erythrocytes), relative density, urobilinogen
Important Notes
For clinical laboratories and POCT sites. Water for dissolution available, see scheme 3101, should be ordered separately
Clinical Chemistry
Specimens
15 mL water for dissolution of lyophilised samples of scheme 3130
Examinations
Water for dissolution
Important Notes
Only in connection with scheme 3130
Clinical Chemistry
Specimens
1 lyophilised urine, 15 mL
Examinations
Particle count: erythrocytes and leukocytes. Estimation of density: creatinine, relative density, osmolality. Strip tests: glucose, ketone bodies, leukocytes, nitrite, pH, protein, blood (erythrocytes)
Important Notes
Also suitable for automatic analysers (erythrocytes and leukocytes counting). The arbitrary concentrations of the obtained strip test results will only be collected in order to avoid different groupings of positive categories used by different strip tests and user laboratories. Water for dissolution of the lyophilized sample available, see scheme 3131, should be ordered separately.
Clinical Chemistry
Specimens
4 digital images
Examinations
Identification of cells and other particles
Important Notes
Clinical Chemistry
Specimens
1 liquid urine, 10 mL
Examinations
Albumin, amylase, calcium, chloride, cortisol-free, creatinine, glucose, inorganic phosphate, magnesium, osmolality, pH, potassium, protein, relative density, sodium, urea, uric acid
Important Notes
Microbiology
Specimens
3 plasma or serum samples, 0.5 mL.
Examinations
Varicella zoster IgG, IgM, total antibodies and post-analytical clinical interpretation
Important Notes